[Bacampicillin vs amoxicillin in respiratory pathology]

Minerva Med. 1986 Apr 21;77(17):663-9.
[Article in Italian]

Abstract

Clinical research was conducted to evaluate the comparative therapeutic efficacy in respiratory pathology of 800 mg X 2 per diem bacampicillin v. 1000 mg X 2 per diem amoxicillin, both orally administered. The results were more or less identical and are interpreted as indicating the better constant absorption of the precursor, hence its higher concentration gradient that produces a higher antibiotic concentration in the lungs.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Amoxicillin / administration & dosage
  • Amoxicillin / therapeutic use*
  • Ampicillin / administration & dosage
  • Ampicillin / analogs & derivatives*
  • Ampicillin / therapeutic use
  • Bacteria / isolation & purification
  • Bacterial Infections / drug therapy*
  • Bronchitis / drug therapy
  • Bronchopneumonia / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / microbiology

Substances

  • Ampicillin
  • Amoxicillin
  • bacampicillin